Assays for α-synuclein aggregation

Area of Science:

• Biochemistry
• Neuroscience
• Structural Biology

Background:

• Alpha-synuclein (α-synuclein) aggregation is central to Parkinson's disease pathogenesis.
• Unlike globular proteins, α-synuclein, a natively disordered protein, can fibrillate under physiological conditions.
• Erratic fibrillation behavior necessitates reproducible methods for studying α-synuclein.

Purpose of the Study:

• To review methods for achieving and monitoring reproducible α-synuclein aggregation.
• To identify conditions that stimulate α-synuclein fibrillation.
• To enable high-throughput screening for potential therapeutic interventions.

Main Methods:

• Investigating factors promoting α-synuclein structure formation (low pH, ions, surfactants, agitation).
• Comparing reproducibility of aggregation using agitation with glass beads versus sub-micellar SDS concentrations.
• Characterizing resulting fibrils for cross-β structure and amenability to screening assays.

Main Results:

• Sub-micellar SDS concentrations significantly enhance the reproducibility of α-synuclein aggregation compared to agitation methods.
• SDS-induced fibrils, though structurally distinct, exhibit cross-β content.
• These reproducible fibrils are suitable for high-throughput screening assays.

Conclusions:

• Reproducible α-synuclein aggregation is achievable using specific conditions, notably sub-micellar SDS.
• This method facilitates the identification of small molecule inhibitors targeting aggregation pathways.
• Further validation in complex biological systems is essential to correlate in vitro findings with in vivo relevance for Parkinson's disease.